Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 16, 2019
CorMedix has completed its interaction with the FDA related to the CMC package that will be needed to support Neutrolin’s NDA.
read more
After one year of re-construction, the new facilities in close proximity to Coriolis’ headquarters in Martinsried will significantly increase Coriolis’ capabilites for ATMP development. Formulation development for ATMPs, including cell culture ...
read more
Coriolis Pharma, a globally operating service provider for R&D and GMP drug product development, R&D and GMP analytics and sterile drug product manufacturing support, announced the launch of a U.S. entity that allows customers to combine the ...
read more
Coriolis Pharma, a globally operating service provider in formulation research and development of biopharmaceutical drugs, announced the expansion of its ATMP development facilities under biosafety level S2 (BSL2).
read more
COREX Logistics announced the establishment of a representative office in Kazakhstan. Its office based in Almaty will serve the needs of international pharma and biotech conducting clinical research in the country.
read more
Thursday, September 05, 2024
CoreRx, Societal CDMO, and Bend Bioscience have announced their unification under the Bend Bioscience brand. This merger brings together three highly respected organizations, each with a unique legacy and distinct strengths, to form a comprehensive ...
read more
Clearwater, Florida -- CoreRx, Inc. today announced plans for an approximately $2 million expansion of its manufacturing capabilities in Clearwater, Florida. The expansion will introduce a new facility for hormone development, clinical trial ...
read more
Continuing to exceed industry expectations, CoreRx, a Tampa-based pharmaceutical development company, added two new critical roles to their growing organization; Director of Commercial Manufacturing, and a Manager of Marketing & Strategic Development...
read more
CoreRx and Aimmune Therapeutics announced their expansion of Myerlake-3.
read more
Wednesday, September 25, 2013
CoreRx, a leader in early pharmaceutical development services, recently announced the addition of Dr. Janice Cacace, who will serve as Director, Formulation Development
read more
CoreRx, Inc., an industry-leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California announces Michael Grass, Ph.D. has joined CoreRx as Senior Director of Product ...
read more
Monday, November 05, 2018
CoreRx has announced the completed installation of the Optel Line Master Serialization and Aggregation System for support of commercial liquid dosage form manufacturing.
read more
CoreRx, Inc. announced the appointment of Dan Dobry as Chief Strategy Officer and a member of CoreRx’s Executive Leadership Team. Dan will report to CoreRx’s Chief Executive Officer, Ajay Damani.
read more
CoreRx, Inc., a CDMO with formulation, development and GMP manufacturing sites in Clearwater, Florida and San Rafael, California, is pleased to announce the appointment of Sitakant (S.K.) Chaudhury as Chief Financial Officer and as a member of CoreRx...
read more
CoreRx, Inc., an industry leading CDMO with formulation development, analytical services and GMP manufacturing sites in Clearwater, Florida and San Rafael, California,
read more